St. Jude Medical's Penta lead
This article was originally published in The Gray Sheet
St. Jude is launching its new Penta neurostimulation lead after obtaining PMA supplement approval in June, the firm announced Dec. 4. According to the firm, the Penta lead provides the broadest lateral electrode span of any neurostimulation lead on the market. A proprietary micro-texturing process enables greater amounts of current to be delivered via the small electrodes, arranged in five columns, providing focused electrical current over a greater lateral area of the spinal cord to control chronic pain, St. Jude says
You may also be interested in...
House and Senate Democrats sponsor legislation to authorize FTC enforcement against sales of "consumer goods and services at an unconscionably excessive price during the" COVID-19 pandemic. "It’s outrageous that some companies and individuals are taking advantage of consumers by price-gouging," says Energy and Commerce Committee Chairman Frank Pallone.
Robert Califf, a former FDA commissioner turned Verily Life Sciences exec, is just one of the voice predicting a long-term impact on clinical trial processes from the COVID-19 outbreak.
A US National Academies meeting on digital health technology showcased the communication gap between regulators and tech developers when it comes to important concepts like “digital biomarkers.”